Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02176356 · ClinicalTrials.gov registry record · Phase 4

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

A Phase 4 study of Glabellar Lines and Facial Rhytides, sponsored by Allergan.

Completed
Registry status
Phase 4
Development phase
116
Enrollment target
1
Study location

NCT02176356 is a Phase 4 study of Glabellar Lines and Facial Rhytides that has completed, run by Allergan. The registered enrollment target is 116 participants, below the 385-participant average among 4 other Glabellar Lines trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02176356, a Phase 4 study of Glabellar Lines and Facial Rhytides, has completed, sponsored by Allergan.

COMPLETED
Registry status
Phase 4
Development phase
116 participants
Enrollment target
1
Study location

Study Summary

A study to evaluate patient satisfaction, aesthetic and psychological impact of combined treatment with BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® ULTRA XC, JUVÉDERM® ULTRA PLUS XC, JUVÉDERM® VOLUMA® XC, and LATISSE® (bimatoprost ophthalmic solution).

Conditions Studied

Glabellar Lines Facial Rhytides Crow's Feet Lines Nasolabial Fold

Interventions

  • DRUG bimatoprost ophthalmic solution 0.03%
  • BIOLOGICAL onabotulinumtoxinA
  • DEVICE JUVÉDERM® ULTRA XC
  • DEVICE JUVÉDERM® ULTRA PLUS XC
  • DEVICE JUVÉDERM® VOLUMA® XC

Study Locations (1)

California

  • - Los Angeles

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2014-06-30
Est. Completion 2015-05-03
Phase Phase 4

Sponsor

Allergan

314 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02176356

The ClinicalTrials.gov registry entry for NCT02176356 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 385-participant average among 4 other Glabellar Lines trials with a reported enrollment target (70% lower). The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Glabellar Lines appearing as the primary indexed condition, and to 5 interventions - of which bimatoprost ophthalmic solution 0.03% is the first listed.

NCT02176356 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02176356 about?

NCT02176356 is a clinical study titled "Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)". A study to evaluate patient satisfaction, aesthetic and psychological impact of combined treatment with BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® ULTRA XC, JUVÉDERM® ULTRA PLUS XC, JUVÉDERM® VOLUMA® XC, and LATISSE® (bimatoprost ophthalmic solution).

What is the current status of trial NCT02176356?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 116 participants. The study started on 2014-06-30. Estimated completion is 2015-05-03.

What conditions does trial NCT02176356 study?

This clinical trial studies the following conditions: Glabellar Lines, Facial Rhytides, Crow's Feet Lines, Nasolabial Fold.

What interventions are being tested in trial NCT02176356?

The interventions under investigation include: bimatoprost ophthalmic solution 0.03% (DRUG), onabotulinumtoxinA (BIOLOGICAL), JUVÉDERM® ULTRA XC (DEVICE), JUVÉDERM® ULTRA PLUS XC (DEVICE), JUVÉDERM® VOLUMA® XC (DEVICE).

Who is sponsoring clinical trial NCT02176356?

This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02176356 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Glabellar Lines

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Glabellar Lines

All registered trials for this condition

Facial Rhytides

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.